Personalized medicine vs MBiL, the Swedish “Patient as a reasonable competent educated (by us) resource and coworker in own rehab”

As the below is discussed  not for the first time. I mean personal tailored biopsychosocial tools in interventions (see e.g.! Also I (I hope to say we) have worked in this way since 1983 and welcome development within this kind of clinical thinking!  By we (read unfortunately “i”)  definitively not the first! I am grateful for the influence of George Kelly (1955) and George Éngel (1977), who also was not the first …

NB that, the below concerns DRUGS adjusted to each individual (how they believe it is possible???)! It may be of interesting of course, at least if outside life style related medicine … but only as a swimming-pad (“while learning to swim” – using e.g. psychophysiological behavioral medicine – drug free)! We do begin (! in traditional medicine!) to understand that drugs are very good for profits but not fore patients! So read carefully the below … Not only inflammation is “a silent killer” (WHO) but many drugs, not only over time may have dark effects while knowledge how individuals are influences is limited understood! But, there are dysfunctions were it is decisive, as in type 1 diabetes!–JWnUb3oY4xE_XGWQdV6RDK2IuJ9q9mTB2u3Jo5RVoT-FinJibjIdA3fJQwovMCFOTqGdPhlLngq6S2UgqvAO-gP6V0g&utm_content=209634478&utm_source=hs_email

“Over the last few decades, medical treatment programs have mostly been one-size fits all. Clinicians prescribe different medication or treatment options to patients based on that disease category. However, patients often respond differently to different treatments, so part of the process is working out the most effective treatment with the least severe side effects. Personalized medicine takes an entirely different approach. It aims to develop a precise clinical picture of a patient based on their unique biological makeup. This depth of information allows clinicians to identify variances in genes, RNA or proteins that could affect their susceptibility to a disease.

“By learning the unique disease characteristics specific to each patient or patient subgroup, personalized medicine aims to design smart and tailored drugs that are directly informed by these characteristics to treat disease in a more precise and targeted manner,” says Dr. Ashley Sanders, a group leader at the Max-Delbrück-Centrum für Molekulare Medizin (MDC) in Berlin, Germany.

While personalized medicine is a new approach in modern medicine, the idea of treating patients as individuals is hardly novel. As early as the second millennium BCE, ancient Egyptian medicine, followed later by Greek medicine, focused heavily on understanding an individual’s health, as well as their circumstances and beliefs. The one-size fits all approach arguably came into common usage with the rise of pharmaceutical companies in the early 20th century. Personalized medicine offers a return to these founding principles of treatment.

More links:

Since 1983, we have developed the concept MBiL, which in English means both COOL, Cheif of One’s Own Life or in the clinical version “The patient who reasonably competently trained (by us) resource and co-worker in their own rehab”! See e.g.

More is to come ..